Tenax Therapeutics (TENX) Preferred Shares (2013 - 2024)

Tenax Therapeutics (TENX) reported Preferred Shares of $196.0 for Q1 2024, down 84.47% sequentially from $1262.0 in Q4 2020.

Tenax Therapeutics (TENX) Preferred Shares (2013 - 2024) Analysis & Trends

Tenax Therapeutics (TENX) has 4 years of Preferred Shares data on file, last reported at $196.0 in Q1 2024.

For the quarter ending Q1 2024, Preferred Shares changed N/A year-over-year to $196.0; the trailing twelve-month figure through Mar 2024 stood at $196.0 (changed N/A YoY), and the FY2020 full-year result was $1262.0, up 31450.0% from the prior year.
Preferred Shares retreated to $196.0 in Q1 2024, from $1262.0 in the prior quarter.
In the past five years, Preferred Shares ranged from a high of $1262.0 in Q4 2020 to a low of $196.0 in Q1 2024.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Preferred Shares (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	-
4	NuCana	279.75 Bn	279.75 Bn	-	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	-
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	-
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	-
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	-
10	Tenax Therapeutics	67,856.40	67,856.40	-	-

Historic Data

Download Data

Date	Value
Mar 31, 2024	196.00
Dec 31, 2020	1,262.00
Dec 31, 2019	4.00
Sep 30, 2019	4.00
Jun 30, 2019	4.00
Mar 31, 2019	55.00
Apr 30, 2013	1.00